Kyriakidou: EMA approval for the first vaccines against Covid variants is important

Kyriakidou: EMA approval for the first vaccines against Covid variants is important
Kyriakidou: EMA approval for the first vaccines against Covid variants is important

Thursday, September 1, 2022, 6:12 p.m

Stock photo
Eurokinissi

“Today’s positive opinions from the European Medicines Agency on the first two mRNA-adapted vaccines, from BioNTech-Pfizer and Moderna, are important to protect Europeans from the potential risk of autumn and winter waves of infections”, stresses the Commissioner of Health and Food Safety Stella Kyriakidou adding that “we must be ready to face another winter with COVID-19”.

“We will now proceed with fast-track approval of these vaccines to ensure that they can be quickly released across the EU,” he adds.

In addition, the Commissioner underlines that “adapted versions of these vaccines are to be used as booster doses targeting the original virus and the Omicron BA.1 subvariant.”

In addition, it adds that they “have been developed to offer increased, broader protection against current and future variants” and states that “subject to EMA’s scientific assessment, we also expect an opinion on the adapted Omicron BA.4 and BA.5 vaccines in the next weeks as part of the expanded vaccine portfolio approach that has characterized our work since the beginning.”

“With the Health Emergency Preparedness and Response Authority (HERA) we acted quickly last spring already to ensure that the contracts were amended so that all member states have access to adapted vaccines in the quantities required in the autumn and winter for the protection of citizens. This is European cooperation and solidarity in action, the basic principle of the EU vaccine strategy”, notes Stella Kyriakidou.

In addition, it calls on “Member States to plan and launch their vaccination campaigns, including adapted vaccines”.

“To support Member States’ efforts, the Commission will soon present actions on vaccination strategies against COVID-19 and define measures to prevent an outbreak of the coronavirus this autumn and winter,” he emphasizes.

Finally, Ms. Kyriakidou states that “the pandemic is not over, but the rapid development and adaptation of vaccines to respond to this virus is one of the greatest successes in the modern history of medicine: let us now take care to protect as much as possible more, for us and our loved ones”.

The article is in Greek

Tags: Kyriakidou EMA approval vaccines Covid variants important

PREV Food supplement boosts covid
NEXT The updated Pfizer and Moderna vaccines for Omicron are also coming to Europe – Green light from EMA